Publication Cover
Reproductive Health Matters
An international journal on sexual and reproductive health and rights
Volume 22, 2014 - Issue sup44: Expanding access to medical abortion
1,920
Views
14
CrossRef citations to date
0
Altmetric
Original Research Articles

The introduction of first trimester medical abortion in Armenia

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Nino Tsereteli, Lia Mamatsashvili, George Tsertsvadze, Tamar Tsereteli & Ingrida Platais. (2023) Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits. The European Journal of Contraception & Reproductive Health Care 28:2, pages 141-146.
Read now
Nana Nimo Appiah-Agyekum. (2018) Medical abortions among university students in Ghana: implications for reproductive health education and management. International Journal of Women's Health 10, pages 515-522.
Read now
Karmen S. Louie, Erica Chong, Tamar Tsereteli, Gayane Avagyan, Ruzanna Abrahamyan & Beverly Winikoff. (2017) Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia. The European Journal of Contraception & Reproductive Health Care 22:1, pages 76-80.
Read now
Tamar Tsereteli, Erica Chong, Karmen Louie, Zaza Bokhua & Beverly Winikoff. (2016) Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia. The European Journal of Contraception & Reproductive Health Care 21:5, pages 367-371.
Read now
Megan Wainwright, Christopher J Colvin, Alison Swartz & Natalie Leon. (2016) Self-management of medical abortion: a qualitative evidence synthesis. Reproductive Health Matters 24:47, pages 155-167.
Read now

Articles from other publishers (9)

Tariku Shimels, Melsew Getnet, Mensur Shafie & Lemi Belay. (2023) Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis. Frontiers in Global Women's Health 4.
Crossref
Nandeeta Samad, Pranta Das, Bright Opoku Ahinkorah, Abdul-Aziz Seidu, James Boadu Frimpong, Joshua Okyere, John Elvis HaganJr.Jr., Mohammad Hayatun Nabi & Mohammad Delwer Hossain Hawlader. (2021) Intimate Partner Violence and Pregnancy Termination in Armenia: Evidence from Nationally-Representative Survey Data. European Journal of Investigation in Health, Psychology and Education 11:2, pages 294-302.
Crossref
Ilana G. Dzuba, Philicia W. Castillo, Manuel Bousiéguez, Elba Margarita Lugo Hernández, José Juan Castañeda Vivar & Patricio Sanhueza Smith. (2020) A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64–70 and 71–77 days of gestation: A retrospective chart review. Contraception 102:2, pages 104-108.
Crossref
Bushra Alam, Amy Kaler & Zubia Mumtaz. (2020) Women’s voices and medical abortions: A review of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology 249, pages 21-31.
Crossref
Tsikouras Panagiotis. (2018) Comparative study for efficacy of termination in first trimester pregnancy using Misoprostol and Mifepristone. Archives of Community Medicine and Public Health, pages 038-046.
Crossref
K. Bettahar, A. Pinton, T. Boisramé, V. Cavillon, S. Wylomanski, I. Nisand & D. Hassoun. (2016) Interruption volontaire de grossesse par voie médicamenteuse. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 45:10, pages 1490-1514.
Crossref
Ingrida Platais, Tamar Tsereteli, Galina Grebennikova, Tatyana Lotarevich & Beverly Winikoff. (2016) Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan. International Journal of Gynecology & Obstetrics 134:3, pages 268-271.
Crossref
Erica Chong, Laura J. Frye, Jen Castle, Gillian Dean, Laurel Kuehl & Beverly Winikoff. (2015) A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.. Contraception 92:3, pages 215-219.
Crossref
Marji Gold & Erica Chong. (2015) If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion. Contraception 92:3, pages 194-196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.